NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A ... the Innovative Licensing and Access Pathway (ILAP) with the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency ...

Wexford-based biopharmaceutical company Coeptis Inc. announced the formation of GEAR Therapeutics, a majority-owned ...

Research from the University of Bath, published on No Smoking Day 2025, shows that integrating smoking cessation support into ...

Although this market success has fuelled further innovation in targeted cancer therapies, it has also created challenges for patients, private payers and governments. In the United States ...

UB researchers have uncovered how heat causes a critical receptor protein within cells to unfold and relay pain.

The four compendia comprise Merative Micromedex ® RED BOOK ®, First Databank FDB MedKnowledge ® Drug Pricing, Elsevier Gold Standard Drug Database, and Wolters Kluwer Medi-Span ® Price Rx ®.

Kennedy said HHS would do a clinical trial on the steroid budesonide, the antibiotic clarithromycin and cod liver oil ...

In the midst of a growing measles outbreak in Texas that has killed one child, Health and Human Services Secretary Robert F.

BRISBANE, Australia & INDIANAPOLIS--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and ...

RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and OS Therapies Inc. (NYSE American:OSTX) on the RedChip Small Stocks, Big Money™ show, a sponsored ...

BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...

In our news wrap Monday, the Supreme Court is taking up a challenge to Colorado's ban on conversion therapies for LGBTQ+ children, a cargo ship collided with an oil tanker in the North Sea, Ukrainian ...